通过阻塞性睡眠呼吸暂停的多模式治疗最大限度地提高结果:系统性审查和元分析
Andrea De Vito1, Aniello Donniacuo2, Giovanni Cammaroto3
1Department of Surgery, ENT Unit, Morgagni-Pierantoni Hospital, HLA of Romagna, Forlì, Italy. dr.andrea.devito@gmail.com.
概括
阻塞性睡眠呼吸暂停 (OSA) 的多模式治疗显著改善了结果. 结合疗法可以降低呼吸暂停-低呼吸指数和爱普沃思睡眠度量得分,同时提高连续正气道压力坚持与单一治疗相比.
科学领域:
- 睡眠医学 睡眠医学
- 呼吸系统医学 呼吸系统医学
- 耳鼻喉科 耳鼻喉科 耳鼻喉科
背景情况:
- 阻塞性睡眠呼吸暂停 (OSA) 是一种普遍的疾病,影响着全球数百万人.
- 目前OSA的治疗方法包括改变生活方式,持续正气道压力 (CPAP) 和手术.
- 单一疗法治疗的有效性对某些患者可能是有限的.
研究的目的:
- 审查和分析现有的关于阻断性睡眠呼吸暂停多模式治疗策略的文献.
- 为了比较组合疗法与单一疗法在治疗OSA中的疗效.
主要方法:
- 一个系统的审查和对47项选定的研究的元分析.
- 评估的结果包括减少呼吸暂停-呼吸暂停指数 (AHI),爱普沃思睡眠度量 (ESS) 评分,并坚持CPAP治疗.
主要成果:
- 与单一疗法相比,多模式干预表明AHI的减少明显更大 (p < 0.05).
- 联合治疗导致ESS得分显著降低 (效果大小-0.618,p <0.05).
- 多模式策略显著增加了CPAP的坚持 (综合效果大小为0.607,p <0.05).
结论:
- 多模式治疗方法是阻断性睡眠呼吸暂停患者的一个有希望的策略.
- 综合疗法在关键OSA结果测量方面显示出优于单一疗法治疗的优势.
- 针对患者量身定制的治疗决策过程对于优化OSA管理至关重要.
相关概念视频
Sleep Apnea
456
Sleep apnea is a condition where breathing stops intermittently during sleep, often leading to significant health issues. Each episode can last from 10 to 20 seconds or more and is frequently accompanied by a brief arousal from sleep. This disturbance, largely unnoticed by the individual, can lead to severe daytime fatigue. Commonly, individuals seek help after being informed by their partners about loud snoring and noticeable breathing pauses during sleep.
The condition is more prevalent among...
The condition is more prevalent among...
456
Management of Insomnia
514
The sleep cycle, an integral part of human health, consists of several stages with distinct characteristics and functions. It begins with a transition from wakefulness to sleep, known as the light sleep phase, followed by the restorative deep sleep phase, essential for physical recovery and growth. The cycle concludes with the Rapid Eye Movement (REM) phase, characterized by high brain activity and vivid dreaming. Insomnia, a prevalent sleep disorder, involves difficulty falling asleep, staying...
514
Chronic Obstructive Pulmonary Disease-V: Management
3.1K
Managing Chronic Obstructive Pulmonary Disease (COPD) involves a multifaceted approach to reduce symptoms, prevent exacerbations, improve overall health status, and slow disease progression. Key strategies include lifestyle modifications, pharmacotherapy, supportive therapies, and, in some cases, surgery. Here is an overview of the primary COPD management strategies:
Smoking Cessation
Smoking Cessation
3.1K
Treatment for Pulmonary Arterial Hypertension: Oxygen Therapy for Respiratory Failure
568
Oxygen therapy has emerged as a significant tool in enhancing the quality of life for patients suffering from pulmonary arterial hypertension (PAH). While this therapy has principally been studied on patients with significant hypoxemia, this therapeutic approach helps prevent potential organ damage and can be administered in the comfort of one's home.
Oxygen therapy is vital in increasing and maintaining blood oxygen levels in PAH patients. As a result, it aids in reducing fatigue,...
Oxygen therapy is vital in increasing and maintaining blood oxygen levels in PAH patients. As a result, it aids in reducing fatigue,...
568
COPD: Management Using Bronchodilators and Corticosteroids
706
Chronic obstructive pulmonary isease (COPD) involves a group of progressive lung disorders characterized by persistent airflow limitation and chronic respiratory symptoms. Asthma-COPD Overlap Syndrome (ACOS), encompassing features of both asthma and Chronic obstructive pulmonary disease (COPD), is a group of progressive lung disorders that includes chronic bronchitis, emphysema, and refractory (non-reversible) asthma. ACOS leads to complex clinical presentations that combine the inflammatory...
706
Heart Failure VI: Adjunct Therapies
239
Additional therapies for treating patients with heart failure (HF) may include procedural interventions, supplemental oxygen, the management of sleep disorders, and nutritional therapy.Procedural InterventionsImplantable Cardioverter-Defibrillator: For patients at risk of life-threatening arrhythmias due to severe left ventricular dysfunction, an Implantable Cardioverter-Defibrillator (ICD) can detect and terminate these arrhythmias, preventing sudden cardiac death and improving survival rates.
239


